Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill
Completed · Not applicable
Conditions studied: Drug Abuse, Schizophrenia, Bipolar Disorder, Major Depressive Disorder
In brief
The purpose of this study is to determine the effectiveness of a behavioral treatment, contingency management, in reducing stimulant use in persons with serious mental illness.
Key facts
- Study ID
- NCT00809770
- Run by
- University of Washington
- People needed
- 176
- Starts
- 2008-04-01
- Expected to finish
- 2013-08-01
- Last updated by the study team
- 2016-11-08
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Enrolled patient at Community Psychiatric Clinic (CPC), a large mental health center in urban Seattle, Washington;
- Between 18 and 65 years of age;
- Diagnosis of of methamphetamine, amphetamine(illegal), or cocaine dependence or abuse;
- CPC medical record diagnosis of schizophrenia, schizoaffective disorder, bipolar I or II, or recurrent major depressive disorder
- Stimulant drug use one month before enrollment;
- Ability to understand written and spoken English;
- CPC clinical case manager must affirm the potential participant's ability to provide informed consent and clinical appropriateness (i.e., safety/severity of mental/substance/ physical health) to participate in the study.
You may not qualify if…
- Any medical/psychiatric condition, or severity of that condition, that, in the opinion of Dr. Ries, the PI, would compromise safe study participation
- Chart defined organic brain disorder or dementia;
- Current participation in a methadone maintenance program;
- Any other circumstances that in the PI's opinion precludes safe study participation.
Where it is running
- Harborview Medical Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.